Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases - a phase II study of the EORTC Lung Cancer Group (08965)

By Dziadziuszko R.   Ardizzoni A.   Postmus P.E.   Smit E.F.   Price A.   Debruyne C.   Legrand C.   Giaccone G.   on behalf of the EORTC Lung Cancer Group  

European Journal of Cancer, Vol. 39, Iss. 9, 2003-06 ,pp. : 1271-1276

Elsevier

Access to resources Recommend Favorite

A prospective quality of life study in patients with locally advanced prostate cancer, treated with radiotherapy with or without regional or interstitial hyperthermia

By Van Vulpen M.   De Leeuw J. R. J.   Van Gellekom M. P. R.   Van Der Hoeven J.   De Graeff A.   Van Moorselaar R. J. A.   Van Der Tweel I.   Hofman P.   Lagendijk J. J. W.   Battermann J. J.  

International Journal of Hyperthermia, Vol. 19, Iss. 4, 2003-01 ,pp. : 402-413

Informa Healthcare

Access to resources Recommend Favorite

Phase II trial of capecitabine combined with docetaxel in previously treated patients with non-small cell lung cancer: A randomized controlled study

By                        

Oncology Letters, Vol. 3, Iss. 4, 2012-01 ,pp. : 761-766

Spandidos Publications

Access to resources Recommend Favorite

Utilization of palliative radiotherapy for breast cancer patients with bone metastases treated with bisphosphonates—Toronto Sunnybrook Regional Cancer Centre experience

By Enright Katherine  

Supportive Care in Cancer, Vol. 12, Iss. 1, 2004-01 ,pp. : 48-52

Springer Publishing Company

Access to resources Recommend Favorite

A study of patients with brain metastases as the initial manifestation of their systemic cancer in a Chinese population

By Jin Jia   Zhou Xinli   Liang Xiaohua   Huang Ruofan   Chu Zhaohui   Jiang Jingwei   Zhan Qiong  

Journal of Neuro-Oncology, Vol. 103, Iss. 3, 2011-07 ,pp. : 649-655

Springer Publishing Company

Access to resources Recommend Favorite